François Redelsperger

François Redelsperger has worked in a variety of roles in the medical and scientific fields since 2007. In 2007, they completed a Master training at Inserm and a Master thesis at Institut de Génétique et Microbiologie. From 2008 to 2012, they were a Postdoctoral Researcher at CNRS - Centre national de la recherche scientifique, where they conducted research on endogenous retroviral envelop proteins during cell-cell fusion. In 2010, they were a Teaching assistant at Université Paris Descartes. From 2012 to 2015, they were a Clinical Trial Manager / Clinical Research Associate - Intern at GSK. From 2015 to 2017, they were a Clinical and Regulatory Affairs Principal Advisor at Qmed Consulting, where they supported medical device companies in developing technical documentation, performing clinical evaluations, and preparing post-marketing surveillance plans. From 2017 to 2018, they were a Scientific Manager at Coloplast, where they wrote literature reviews, clinical evaluation plans and reports, and provided scientific advice. Since 2019, they have been a Senior Clinical & Scientific Affairs Manager and Clinical & Regulatory Manager at Neurescue, where they are responsible for scientific writing, clinical activities, submission of applications to EC and CA in Europe, and vigilance data review.

François Redelsperger has a diverse educational background. François obtained a Master in Molecular and Cellular Biology/Speciality Virology from Pierre and Marie Curie University in 2006-2008, followed by a PhD in Virology, Molecular and Cellular Biology from Université Paris Cité in 2008-2011. François also completed a Diplome universitaire in Virology from Institut Pasteur in 2008. In 2011, they earned a FELASA C in Animal Experimentation from Université Paris Cité. Finally, in 2015, they obtained a Clinical Research Associate from INSEEC Executive - Supsanté. François has also obtained several certifications, including ISO 13485 Foundations Course from Advisera Expert Solutions Ltd in 2022, GCP Audit - for Supplier Audits & Clinical Investigations inc. ISO14155:2020 from Whitehall Training in 2022, and Introduction to Risk Management for Medical Devices and ISO 14971:2019 from Gantus AB in 2020.